Related by context. All words. (Click for frequent words.) 78 compound ITMN 75 MEK inhibitor 74 JAK inhibitor 74 oral prodrug 74 PDE4 inhibitor 74 PEG SN# 73 pan HDAC inhibitor 73 orally administered inhibitor 73 stable nucleic acid 73 non nucleoside inhibitor 73 ALN PCS 73 histone deacetylase HDAC inhibitor 72 polymerase inhibitor 72 targeted radiotherapeutic 72 virus HCV protease inhibitor 71 CCX# 71 ketolide antibiotic 71 IMA# 71 investigational humanized monoclonal antibody 71 liposomal formulation 71 Nanobody 71 ALN TTR 71 anticancer compound 71 MT# MEDI 71 Ridaforolimus 71 GSK '# 70 forodesine 70 multi kinase inhibitor 70 NVA# 70 huC# DM4 70 Aurora kinase inhibitor 70 ALN TTR# 70 phase IIb clinical 70 IMiDs R 70 Mipomersen 70 trastuzumab DM1 T DM1 70 proteasome inhibitor 70 HCV protease 70 PNP inhibitor 70 systemic RNAi therapeutic 70 investigational pan BCR 70 PHX# 70 metaglidasen 69 Nanobody ® 69 Tarvacin TM 69 nucleoside analog 69 inhaled formulation 69 Azedra 69 Traficet EN 69 mertansine 69 Factor VIIa 69 PI3K/Akt pathway inhibitor 69 Elvitegravir 69 JAK1 69 humanized monoclonal antibody 69 Panzem R 69 ALN VSP 69 R#/MEM # 69 MAGE A3 ASCI 69 TRO# 69 lipid nanoparticle 69 CCR5 antagonist 69 hepatology portfolio 69 humanized anti 69 BAY #-# 69 JAK2 inhibitor 69 AEG# 69 orally bioavailable 69 lexidronam injection 69 Iluvien ® 69 antisense drug 69 Civacir 69 ATL# [001] 68 ADP receptor antagonist 68 mGluR5 negative 68 Tesetaxel 68 PNT# 68 dextromethorphan quinidine 68 tiapamil 68 elotuzumab 68 IMiDs ® 68 rNAPc2 68 long acting muscarinic 68 RhuDex ® 68 ABL inhibitor 68 Solazed TM 68 Aurora kinase 68 docetaxel Taxotere R 68 YONDELIS 68 Dapagliflozin 68 mitogen activated ERK kinase 68 Nexavar ® 68 RGB # 68 MKC# MKC# PP 68 XL# XL# 68 non nucleoside HCV 68 radezolid 68 protein kinase inhibitor 68 thymalfasin 68 Sym# 68 selective androgen receptor modulator 68 Tezampanel 68 alvespimycin 68 ENMD # 68 histone deacetylase inhibitor 68 novel histone deacetylase 68 ALN HPN 68 HCD# [002] 68 intranasal formulation 68 HQK 68 OncoVEX GM CSF 68 HDAC Inhibitor 68 CEQ# 68 FOLOTYN ® 68 delivered RNAi therapeutic 68 IAP inhibitors 68 integrase inhibitor 68 Tyrima 68 Zenvia ™ 68 Onco TCS 68 polymerase inhibitors 68 vinca alkaloid 67 therapeutic monoclonal antibody 67 immunotherapeutic vaccine 67 transcriptase inhibitor NNRTI 67 glucokinase activator 67 angiogenesis inhibitor 67 myelofibrosis polycythemia vera 67 RNAi therapeutic targeting 67 docetaxel Taxotere ® 67 AP# [003] 67 TG# [003] 67 KNS # 67 LY# [003] 67 delivers fluocinolone acetonide FA 67 hormone LHRH antagonist 67 DiLA2 67 rxRNA 67 topically applied SEPA 67 oral proteasome inhibitor 67 oral antiviral 67 oral nucleoside analogue 67 Guanilib 67 thiazolides 67 Besivance 67 acetonide FA 67 XmAb# 67 Pafuramidine 67 Cetrorelix 67 BiTE antibody 67 chimeric monoclonal antibody 67 INCB# [002] 67 HCV polymerase 67 PSMA ADC 67 nicotinic alpha 7 67 INTEGRILIN 67 INCB# [001] 67 renin inhibitor 67 Phase IIb clinical trials 67 vascular disrupting agent 67 novel VDA molecule 67 apricitabine ATC 67 ocular formulation 67 PrevOnco 67 HIV integrase inhibitor 67 NXL# 67 Ozarelix 67 anti CD3 monoclonal 67 sodium Injection 67 obatoclax 67 pradefovir 67 PEG Interferon lambda 67 Vicriviroc 67 PRT# 67 Reverset 67 deforolimus 67 DB# [003] 67 Dalbavancin 67 oral ridaforolimus 67 2 methoxyestradiol 67 Virulizin ® 67 receptor tyrosine kinase inhibitor 67 Onalta ™ 67 investigational oral inhibitor 67 CCR9 antagonist 67 Archexin 67 evaluating tivozanib 67 nucleoside polymerase inhibitor 67 Ceflatonin 67 small molecule Hedgehog 67 Voreloxin 67 PLK1 SNALP 67 nucleotide analogue 67 BCR ABL inhibitors 67 SAR# [004] 67 selective immunoproteasome inhibitor 67 registrational 67 reslizumab 67 Intravenous Human 67 IAP inhibitor 66 signal transduction inhibitor 66 HCV NS5B polymerase 66 CYT# potent vascular disrupting 66 Zolinza 66 Cethromycin 66 ZEVALIN ® 66 registrational trial 66 Phase 2a trial 66 VQD 66 HGS# 66 recombinant subunit vaccine 66 novel topoisomerase 66 Plicera 66 CR# vcMMAE 66 Elagolix 66 2 inhibitor CYT# 66 PRTX 66 TBC# 66 BYETTA ® 66 SinuNase ™ 66 COX Inhibiting Nitric Oxide 66 RECOTHROM R 66 hypoxia selective 66 OMNARIS HFA 66 selective androgen receptor modulators 66 EndoTAG TM -1 66 Xanafide 66 generation antisense 66 tezampanel 66 MT#/MEDI-# 66 Pimavanserin 66 Fc fusion protein 66 pertuzumab 66 Nanobody R 66 Phase IIa trials 66 PS# [001] 66 FUSILEV ® 66 Ostabolin C 66 Phase 2b clinical 66 Aurexis 66 Talabostat 66 GRNVAC1 66 Enhanze Technology 66 Tanespimycin 66 Phase #b/#a clinical 66 Myocet 66 antibody fragment 66 Pazopanib 66 IL# PE#QQR 66 Kosan dependence 66 molecular imaging radiopharmaceutical 66 ganetespib 66 P#X# antagonist 66 Bezielle 66 nanopharmaceutical 66 Copegus ribavirin 66 Carfilzomib 66 Hsp# Inhibitor 66 highly selective inhibitor 66 Hsp# inhibitor 66 XL# anticancer compounds 66 telaprevir VX 66 novel peptide 66 Ceflatonin R 66 Microplasmin 66 AAG geldanamycin analog 66 siRNA therapeutic 66 HIV protease inhibitor 66 candidate deforolimus 66 Personalized Immunotherapy 66 anti TNF alpha 66 PDX pralatrexate 66 SPL# Gel vaginal microbicide 66 Aganocide ® 66 OncoVEX 66 PKC# 66 IMiD 66 EZN 66 Shigamabs ® 66 XL# XL# XL# 66 IMC #B 66 CYC# 66 sorafenib tablets 66 OncoVex 66 CRLX# 66 DPP4 inhibitor 66 SCH # 66 Alocrest 66 Maribavir 66 Phase 1b trial 66 GW# [003] 66 trastuzumab emtansine T DM1 66 Daclizumab 66 IMiDs ® compound 66 Anticalin R 66 elvucitabine 66 Onalta 66 cyclophilin inhibitor 66 LymphoStat B TM 66 subcutaneous formulation 66 immunotherapeutic agent 66 HepeX B TM 66 CORT # 66 anticancer agent 66 vascular disrupting agents 66 HCV polymerase inhibitors 66 investigational HCV polymerase 66 investigational compound 66 SAR# [002] 66 THR beta agonist 66 octreotide acetate 66 lesinurad 66 AzaSite Plus 66 Liprotamase 66 Sphingomab TM 66 MKC# MT 65 Chemophase 65 R#/MEM 65 Diabetic Macular Edema DME 65 exon skipping 65 ELND-#/AZD-# 65 phase IIa clinical 65 Squalamine 65 MAXY alpha 65 investigational hepatitis C 65 TACI Ig 65 evaluating satraplatin 65 Nexavar sorafenib 65 Lenocta 65 small molecule thrombopoietin 65 leading oral taxane 65 Phase Ib study 65 VitiGam 65 octreotide implant 65 ZOLINZA 65 RDEA# 65 TRX1 65 SERMs 65 Trofex TM 65 investigational oral 65 BiTE 65 therapeutic monoclonal antibodies 65 IgG1 monoclonal antibody 65 ISENTRESS raltegravir 65 HuLuc# 65 vidofludimus 65 generation purine nucleoside 65 HIV integrase inhibitors 65 histone deacetylase HDAC 65 favorable pharmacokinetic profile 65 Azedra ™ 65 Oral NKTR 65 Virulizin R 65 delivery polymer matrix 65 DDP# 65 Unit Dose Budesonide 65 methylnaltrexone bromide 65 UPLYSO 65 celgosivir 65 cardio renal 65 dasatinib Sprycel ® 65 epothilones 65 Azedra TM 65 phase Ib clinical 65 cathepsin K inhibitor 65 kinase inhibitor 65 fosbretabulin 65 RNAi therapeutic 65 thalidomide Thalomid 65 ATL/TV# 65 Bicifadine 65 ISIS # 65 orally bioavailable mimics 65 Alinia 65 Pertuzumab 65 Stapled Peptide 65 VISICOL R 65 PSN# [002] 65 Debio 65 selective antagonist 65 TKB# 65 Pathway Inhibitor 65 investigational antiplatelet agent 65 MEK Inhibitor 65 humanized monoclonal 65 trastuzumab Herceptin R 65 HCV polymerase inhibitor 65 maturation inhibitor 65 Ampligen ® 65 MEK inhibitors 65 TLK# 65 Solazed ™ 65 erlotinib Tarceva ® 65 investigational oral hepatitis C 65 Pradefovir 65 ARIKACE 65 oral taxane 65 product platforms AZX# 65 atrasentan 65 tanespimycin 65 Ixempra 65 synthetic retinoid 65 RELOVAIR ™ 65 generation Hsp# inhibitor 65 lomitapide 65 small molecule glucokinase 65 Locteron 65 SARMs 65 somatostatin analogue 65 Maraviroc 65 Curaxin CBLC# 65 SNALP technology 65 Spiegelmer ® 65 DNA RNA Medicines 65 sulfonylhydrazine class 65 targeted antifolate 65 DermaVir Patch 65 Altastaph 65 PI3K inhibitor 65 transthyretin mediated amyloidosis ATTR 65 microtubule inhibitor 65 targeting CD# 65 PXD# 65 selective kinase inhibitor 65 Zorbtive TM 65 alpha folate receptor 65 immunomodulator 65 orally dosed 65 multicenter Phase II 65 MGCD# [001] 65 ArQule Kinase Inhibitor Platform 65 Aflibercept 65 AEZS 65 CD# monoclonal antibody 65 volociximab 65 tafamidis 65 ASG 5ME 65 LentiVector technology 65 IRX 2 65 RNAi Therapeutic 65 OMP #R# 65 peripherally acting 65 cetuximab Erbitux ® 65 samarium Sm 65 regorafenib 65 danoprevir 65 epothilone 65 Blinatumomab 65 renin inhibitors 65 anti CD# monoclonal 65 BXT # 65 Prodarsan ® 65 BLP# Liposome Vaccine 65 Angiocept 65 selective orally bioavailable 65 luteinizing hormone releasing 65 AEGR 65 NS5A inhibitor 65 anticoagulant reversing agent 65 herpetic keratitis 65 INT# [002] 65 highly selective adenosine 65 AKT inhibitor 65 oral ghrelin agonist 65 Resten NG 65 5 HT3 antagonist 65 developing Zerenex TM 65 Genasense ® oblimersen 65 Dasatinib 65 phase IIb trial 65 patented Bioral 65 Lixivaptan 65 severe hypercholesterolemia 65 MyVax R 64 novel immunomodulatory 64 telomerase therapeutic 64 MORAb 64 investigational protease inhibitor 64 Onconase 64 trastuzumab Herceptin 64 EOquin 64 administered subcutaneously 64 talactoferrin 64 beta 1a 64 modulator SERM 64 diarrhea predominant irritable 64 nitric oxide donating prostaglandin 64 dacetuzumab 64 IND submission 64 etanercept Enbrel 64 acyclovir Lauriad R 64 GSK# [001] 64 Cleviprex TM clevidipine 64 Zemiva TM 64 Fleximer 64 MAP# 64 CytoFabTM 64 Clolar ® 64 PEGylated interferon 64 Palifosfamide 64 oral beclomethasone dipropionate 64 Relivar 64 immunotherapeutic 64 custirsen 64 ThermoDox R 64 CK # novel 64 nucleotide analog 64 humanized antibody 64 Locteron ® 64 CUDC 64 REG1 Anticoagulation System 64 CCR5 receptor antagonist 64 ABILIFY ® 64 CD# antibody [001] 64 Telatinib 64 Atripla combines 64 sodium thiosulfate STS 64 CobaCyte 64 Panzem 64 eniluracil 64 HuMax EGFr 64 Laquinimod 64 immunomodulating 64 Tarmogen 64 LymphoStat B belimumab 64 DAVANAT R 64 TYZEKA 64 FACTIVE R gemifloxacin 64 oral salmon calcitonin 64 Copegus R 64 TKM ApoB 64 lumiliximab 64 DEB# 64 ORENCIA R 64 mesylate tablets 64 SPC# [001] 64 Trofex 64 fostamatinib 64 Protexia ® 64 pomalidomide 64 transdermal spray 64 ApoB SNALP 64 DexaSite 64 JAK2 Inhibitor 64 Hedgehog antagonist 64 bevacizumab Avastin ® 64 NovaBay Aganocide compounds 64 TELINTRA 64 investigational monoclonal antibody 64 tenofovir disoproxil fumarate 64 investigational compounds 64 refractory gout 64 Solzira ™ 64 EDEMA3 64 Micromet BiTE 64 AzaSite Xtra 64 TPI ASM8 64 Methylnaltrexone 64 inhibitor RG# 64 oral Factor Xa 64 XP# XP# 64 solithromycin 64 axitinib 64 Kinase Inhibitor 64 Copegus ® 64 Lenocta TM 64 alkylating agent 64 sapropterin dihydrochloride 64 ITMN 64 Phase Ib clinical 64 sodium glucose cotransporter 64 GSK# [002] 64 Phase Ib clinical trials 64 BARACLUDE R 64 ALN HTT 64 HSP# inhibitor 64 DsiRNA 64 Luteinizing Hormone Releasing Hormone 64 Aganocide 64 dyskinesia PD LID 64 LNPs 64 MAXY G# 64 HIV integrase 64 Curaxin 64 Ixabepilone 64 sunitinib malate 64 Proxinium TM 64 RAPAFLO 64 velafermin belinostat 64 Vidofludimus 64 Xeloda ® 64 LymphoStat B 64 CRMD# 64 Vfend 64 orally inhaled 64 drug conjugate 64 romazarit 64 atacicept 64 Aliskiren 64 bortezomib Velcade ® 64 LY# [002] 64 Temsirolimus 64 pan histone deacetylase 64 Romidepsin 64 SPRYCEL ® 64 SUTENT ® 64 paclitaxel Taxol ® 64 NKTR 64 Campath ® 64 HFA MDI 64 NEUGENE 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 INVANZ 64 Homspera TM 64 CIMZIA TM 64 lenalidomide Revlimid R 64 drug pipeline TAFA# 64 small molecule defensin 64 HepeX B 64 AtuRNAi 64 hepatitis C protease inhibitor 64 DXL# 64 Vilazodone 64 PROSTASCINT R 64 lorvotuzumab mertansine 64 VA# [002] 64 Cloretazine 64 MOVIPREP R 64 NUEDEXTA ™ 64 JAK inhibitors 64 HuMax CD4 64 ceftazidime 64 Rigel R# 64 SNT MC# 64 sulodexide 64 proprietary PEGylation 64 Preclinical studies suggest 64 Prodarsan R 64 Tarceva TM 64 CIMZIA ™ 64 Belimumab 64 cilengitide 64 Omacetaxine 64 candidate CRLX# 64 Amigal 64 corticosteroid dexamethasone 64 PARP inhibitor 64 Immunotherapeutic 64 GPR# agonist 64 immunosuppressant drug 64 ELACYT 64 Abiraterone acetate 64 Soliris eculizumab 64 anti amnesic 64 fusion inhibitor 64 protease inhibitor telaprevir 64 phase III isavuconazole 64 Boceprevir 64 DU #b 64 BUPHENYL R 64 novel oral anticoagulant 64 RG# ITMN 64 Amrubicin 64 class anticancer quinolone 64 OXi# 64 Quinamed 64 Varespladib 64 ISENTRESS 64 Aganocide R 64 NS#/#A protease 64 relapsed multiple myeloma 64 ARIKACE ™ 64 HGS ETR1 mapatumumab 64 systemically administered 64 Pegasys R 64 dextofisopam 64 HCV protease inhibitors 64 HGS ETR1 64 Fx #A 64 compound INCB# 64 oral Hsp# inhibitor 64 enzastaurin 64 class oral heparinoid 64 DOS# 64 gefitinib Iressa 64 BCX# 64 panitumumab Vectibix 64 oral dihydropyrimidine dehydrogenase DPD 64 Golimumab 64 proteasome inhibitors 64 posaconazole 64 VaxImmune 64 Thiovir 64 novel anticancer 64 Valopicitabine 64 PrevOnco ™ 64 antisense inhibitors 64 huN# DM1 64 Oracea TM 64 COLAZAL R 63 ZADAXIN ® 63 arsenic trioxide injection 63 Evoltra ® 63 PolyActive ® 63 Irinotecan 63 SinuNase TM 63 CD3 monoclonal antibody 63 Gemzar ® 63 radiation sensitizer 63 selective modulator 63 RLY# 63 Ramoplanin 63 AERx iDMS 63 Excellarate 63 sorafenib Nexavar 63 REG1 63 Interferon alpha 63 Sapacitabine 63 TREANDA 63 Marqibo TM 63 refractory chronic lymphocytic 63 OHR/AVR# 63 CBLC# 63 VivaGel ™ 63 MNTX 63 Azixa 63 allosteric modulator NAM 63 Phase 2b clinical trials 63 XL# XL# XL# XL# 63 Neulasta R 63 GALNS 63 RAV# 63 trabectedin 63 Junovan TM 63 Hepatitis C Virus HCV 63 Tarvacin 63 Hedgehog pathway inhibitor 63 Restanza 63 methylnaltrexone 63 CD4 monoclonal antibody 63 Solazed 63 PARI Pharma GmbH 63 ARRY # 63 Prednisporin 63 selective adenosine 63 Intravenous CP 63 Tiuxetan 63 cetuximab Erbitux R 63 DUROS 63 ospemifene 63 oncolytic virus therapies 63 novel prodrug 63 relapsed refractory multiple myeloma 63 compound PMX # 63 TAFA# 63 Muraglitazar 63 mapatumumab 63 LHRH antagonist 63 allosteric modulator 63 delta opioid receptor 63 GLPG# 63 Trastuzumab 63 PTH analogue 63 APTIVUS 63 tasocitinib 63 ongoing Phase 1b 63 Anidulafungin 63 Sustiva efavirenz 63 GLP toxicology studies 63 Hedgehog Pathway Inhibitor 63 pseudobulbar affect PBA 63 antisense oligonucleotide 63 Crofelemer 63 Novolimus 63 NEBIDO R 63 Belinostat 63 LNP formulations 63 Allovectin 7 63 Phase 2b Clinical Trial 63 R sorafenib tablets 63 Safinamide 63 Alnylam #x# 63 MGd 63 Albuferon TM 63 ZALBIN 63 acting muscarinic antagonist 63 nitric oxide donating 63 Kamada AAT 63 Ceflatonin ® 63 OMNARIS Nasal Spray 63 RANK Ligand inhibitor 63 Valortim 63 Epothilones 63 TLR9 agonist 63 oral JAK#/JAK# inhibitor 63 POTELLIGENT ® 63 BCR ABL inhibitor 63 echinocandin 63 Fodosine 63 darinaparsin ZIO 63 MVA BN R 63 XmAb ® 63 tubulin inhibitor 63 TMC# [002] 63 DPX Survivac 63 Captisol Enabled 63 Aptivus ® 63 anti CD3 63 mTOR inhibitor 63 BMS # 63 interferon gamma 1b 63 Aztreonam 63 KSP inhibitor 63 Rebif ® 63 SLx 63 Leukine ® 63 oral dual endothelin 63 TRAIL receptor antibodies 63 cell lymphoma CTCL 63 adecatumumab MT# 63 BioNumerik 63 XmAb 63 delipidation 63 APEX PD 63 ulimorelin 63 Intarcia 63 DAVANAT 63 albiglutide 63 Phenoptin 63 cutaneous T 63 product Fentanyl TAIFUN 63 Abbokinase 63 Panzem R NCD 63 Ceftaroline 63 AQ4N 63 PDE# inhibitors 63 tkRNAi 63 ANYARA 63 Onalta TM 63 oral picoplatin 63 pexiganan 63 investigational immunotherapy 63 antagonist LAMA 63 isoform selective 63 Alzhemed TM 63 INTEGRILIN ® 63 antibody MAb 63 AVONEX ® 63 HDL Mimetic Peptide 63 QUADRAMET R 63 IPL# 63 aleglitazar 63 BLA submission 63 Telaprevir 63 AVE# 63 BiTE R 63 topical antifungal 63 LHRH antagonists 63 BEMA TM Fentanyl 63 intravesical infusion therapy 63 Elotuzumab 63 Glufosfamide 63 IMMU 63 Naproxcinod 63 Omacetaxine mepesuccinate 63 EOquin TM 63 rHuPH# enzyme 63 Troxatyl 63 Locked Nucleic Acid LNA 63 albinterferon alfa 2b 63 omega interferon 63 PULSYS 63 subcutaneously administered 63 pegylated interferon alpha 63 LEUKINE 63 oral Azacitidine 63 c Raf kinase 63 XmAb ™ 63 estrogen receptor antagonist 63 Phase Ib II 63 investigational integrase inhibitor 63 HIV maturation inhibition 63 ritonavir boosted 63 Phase #b/#a trial 63 GVAX ® 63 hormone agonist 63 Proellex TM 63 UltiMAb 63 topical ophthalmic 63 HTS assay 63 Nanobodies 63 Silodosin 63 GRN#L 63 ONCONASE R 63 brivaracetam 63 budesonide foam 63 Anthim 63 MYDICAR ® 63 paclitaxel Taxol 63 Fibrillex TM 63 Enzastaurin 63 ThermoDox ® 63 virus HCV infection 63 cangrelor 63 YONDELIS R 63 INC# 63 FDA APPROVES 63 CCR5 mAb 63 systemic RNAi 63 Diovan Exforge Tekturna Zelnorm 63 CA4P 63 Phase 2a clinical 63 candidate ATHX 63 Phase IIIb clinical 63 AVASTIN 63 Surfaxin LS 63 Amplimexon 63 Phase Ib 63 topical gel containing 63 monoclonal antibody conjugated 63 HGS ETR2 63 Xcytrin R 63 adalimumab Humira 63 IND enabling 63 Alfacell proprietary ribonuclease 63 candidate ridaforolimus 63 MTP inhibitor 63 Moxifloxacin 63 Azilect ® 63 isatoribine 63 essential thrombocythemia ET 63 nitazoxanide 63 BAL# [001] 63 CD# CEA 63 GTC recombinant human 63 HCV nucleotide polymerase inhibitor 63 vapreotide acetate 63 CTCE 63 PROVENGE sipuleucel T 63 imatinib Gleevec ® 63 plasma kallikrein inhibitor 63 FGFR 63 Loramyc R 63 CDP# 63 ANAVEX #-# [003] 63 PEGPH# 63 zanolimumab 63 BENLYSTA ® 63 Optiquel ™ 63 Solzira TM 63 Ecallantide 63 targeting PCSK9 63 Menadione 63 ularitide 63 immune modulating 63 Aviptadil 63 Fludara ® 63 VEGF Trap 63 TLR9 agonists 63 Tasimelteon 63 PORxin TM 63 Exherin TM 63 developing TB4 63 INS# [001] 63 otelixizumab 63 Polymerase Inhibitor 63 thrombolytic agent 63 ESBATech 63 selective estrogen receptor modulator 63 antagomirs 63 Actemra tocilizumab 63 familial amyloidotic polyneuropathy FAP 63 Valortim TM 63 PRX # 63 lucinactant 63 recombinant biopharmaceutical 63 Akt inhibitor 63 Zalbin 63 PLX# 63 rilonacept 63 humanized antibodies 63 preclinical efficacy 63 investigational pharmacologically unique 63 Protease Inhibitor 63 alpha interferon 63 CoFactor 62 personalized cellular immunotherapy 62 GAMMAGARD 62 dirucotide 62 phosphatidylserine PS targeting 62 candidate Zenvia 62 NeuroSTAT ® 62 Eltrombopag 62 external counterpulsation systems 62 ponatinib 62 nucleoside analogue 62 non alcoholic steatohepatitis 62 Viprovex R 62 immatics